Kanro Inc. logo

Kanro Inc. (2216)

Market Closed
3 Mar, 06:00
JPX JPX
¥
1,321. 00
-78
-5.58%
¥
- Market Cap
- P/E Ratio
- Div Yield
242,800 Volume
- Eps
¥ 1,399
Previous Close
Day Range
1,321 1,392
Year Range
950 2,470
Want to track 2216 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
2216 earnings report is expected in 52 days (24 Apr 2026)

Summary

2216 closed today lower at ¥1,321, a decrease of 5.58% from yesterday's close, completing a monthly decrease of -4.83% or ¥67. Over the past 12 months, 2216 stock lost -21.42%.
2216 pays dividends to its shareholders, with the most recent payment made on Mar 01, 2026. The next estimated payment will be in In 5 months on Sep 01, 2026 for a total of ¥16.
The last earnings report, released on Jul 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Apr 24, 2026.
Kanro Inc. has completed 4 stock splits, with the recent split occurring on Jun 27, 2025.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2216 Chart

Kanro Inc. (2216) FAQ

What is the stock price today?

The current price is ¥1,321.00.

On which exchange is it traded?

Kanro Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 2216.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Apr 24, 2026.

Has Kanro Inc. ever had a stock split?

Kanro Inc. had 4 splits and the recent split was on Jun 27, 2025.

Kanro Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Hong Xu CEO
JPX Exchange
- ISIN
China Country
171 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Broncus Holding Corporation is a pioneering medical device company dedicated to advancing the field of interventional pulmonology. Established in 2012 and headquartered in Hangzhou, China, the company engages in the development and distribution of innovative products across Mainland China, the European Union, the United States, and other international markets. Its portfolio spans navigation and treatment products for lung diseases, as well as diagnostic tools that cater to the needs of the pulmonology community. By focusing on breakthrough technologies, Broncus aims to improve patient outcomes and enhance the precision and effectiveness of lung disease management.

Products and Services

  • LungPoint Virtual Bronchoscopic Navigation: A sophisticated computer-assisted image-based navigation software system designed to enhance the accuracy of lung navigations and interventions.
  • LungPoint Plus/Archimedes Lite: This system offers real-time navigation within the airways, facilitating lung biopsies and other pulmonary procedures with greater precision.
  • LungPro: A virtual bronchoscopic navigation tool providing three-dimensional, real-time guided transbronchial needle aspiration and proprietary parenchymal navigation, aimed at improving diagnostic yield and procedural safety.
  • InterVapor: A bronchoscopic thermal vapor ablation system targeted at diseased hyper-inflated lung segments to ablate them effectively, offering a non-surgical option for lung volume reduction.
  • RF Generator + RF Ablation Catheter: This radiofrequency ablation system, used in conjunction with a disposable lung radiofrequency ablation catheter, targets lung cancer by applying heat to destroy cancer cells.
  • H-Marker: A pulmonary surgical marker that assists surgeons in precisely locating lung nodules during surgical pneumonectomy, enhancing surgical accuracy.
  • BioStarNeedle: A single-use ultrasound-guided aspiration needle designed for the retrieval of tissue samples, facilitating accurate diagnoses of lung conditions.
  • FleXNeedle: A versatile biopsy needle that can be used for multiple purposes, including lung biopsies, providing flexibility and efficiency in pulmonary procedures.
  • Archimedes Sheath: A sterile, single-use flexible tube that offers a working channel during bronchoscopic procedures, improving access and maneuverability.
  • Archimedes Dilation Balloon: A balloon catheter used to dilate target lung tissue of the bronchial tree, aiding in the treatment of stenoses and facilitating other interventional procedures.
  • Steerable Sheath: This device features an adjustment handle and a working channel, enabling precise steering and positioning during bronchoscopic interventions, thus enhancing procedural outcomes.

Contact Information

Address: Building 8
Phone: 86 571 8659 5016